Standard of Care for Neuropsychological Monitoring in Pediatric Neuro-Oncology: Lessons From the Children's Oncology Group (COG)

被引：47

作者：

Walsh, Karin S. ^{[1
,2
]}

Noll, Robert B. ^{[3
]}

Annett, Robert D. ^{[4
]}

Patel, Sunita K. ^{[5
]}

Patenaude, Andrea F. ^{[6
]}

Embry, Leanne ^{[7
]}

机构：

[1] Childrens Natl Hlth Syst, Dept Pediat Neuropsychol, Washington, DC USA

[2] George Washington Univ, Sch Med, Washington, DC USA

[3] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA

[4] Univ Colorado Denver, Childrens Hosp Colorado, Aurora, CO USA

[5] City Hope Natl Med Ctr, Behav Res Sect, Dept Pediat, Med Ctr, Duarte, CA USA

[6] Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA

[7] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat Hematol Oncol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA

来源：

PEDIATRIC BLOOD & CANCER | 2016年 / 63卷 / 02期

关键词：

late effects; pediatric oncology; psychology; CHILDHOOD-CANCER SURVIVOR; LONG-TERM SURVIVORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; NEUROCOGNITIVE STATUS; COST-EFFECTIVENESS; ADULT SURVIVORS; BRAIN-TUMORS; OUTCOMES; HEALTH; MEDULLOBLASTOMA;

D O I：

10.1002/pbc.25759

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

As the mortality of pediatric cancers has decreased, focus on neuropsychological morbidities of treatment sequelae have increased. Neuropsychological evaluations are essential diagnostic tools that assess cognitive functioning and neurobiological integrity. These tests provide vital information to support ongoing medical care, documenting cognitive morbidity and response to interventions. We frame standards for neuropsychological monitoring of pediatric patients with CNS malignancy or who received cancer-directed therapies involving the CNS and discuss billing for these services in the United States in the context of clinical research. We describe a cost-effective, efficient model of neuropsychological monitoring that may increases access to neuropsychological care. (c) 2015 Wiley Periodicals, Inc.

引用

页码：191 / 195

页数：5

共 50 条

[31] Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group
Martin-Giacalone, Bailey A.
Richard, Melissa A.
Scheurer, Michael E.
Khan, Javed
Sok, Pagna
Shetty, Priya B.
Chanock, Stephen J.
Li, Shengchao Alfred
Yeager, Meredith
Marquez-Do, Deborah A.
Barkauskas, Donald A.
Hall, David
McEvoy, Matthew T.
Brown, Austin L.
Sabo, Aniko
Scheet, Paul
Huff, Chad D.
Skapek, Stephen X.
Hawkins, Douglas S.
Venkatramani, Rajkumar
Mirabello, Lisa
Lupo, Philip J.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (06): : 733 - 741
[32] Psychosocial Late Effects in Pediatric Cancer Survivors: A Report From the Children's Oncology Group
Bitsko, Matthew J.
Cohen, Debra
Dillon, Robyn
Harvey, Jeanne
Krull, Kevin
Klosky, James L.
PEDIATRIC BLOOD & CANCER, 2016, 63 (02) : 337 - 343
[33] Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group
Athale, Uma H.
Gibson, Paul J.
Bradley, Nicole M.
Malkin, David M.
Hitzler, Johann
PEDIATRIC BLOOD & CANCER, 2016, 63 (06) : 973 - 982
[34] Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group
Ehrlich, Peter F.
Hamilton, Thomas E.
Gow, Kenneth
Barnhart, Douglas
Ferrer, Fernando
Kandel, Jessica
Glick, Richard
Dasgupta, Roshni
Naranjo, Arlene
He, Ying
Perlman, Elizabeth J.
Kalapurakal, John A.
Khanna, Geetika
Dome, Jeffrey S.
Geller, James
Mullen, Elizabeth
PEDIATRIC BLOOD & CANCER, 2016, 63 (11) : 1905 - 1910
[35] Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group
Esbenshade, Adam J.
Kahalley, Lisa S.
Baertschiger, Reto
Dasgupta, Roshni
Goldsmith, Kelly C.
Nathan, Paul C.
Harker-Murray, Paul
Kitko, Carrie L.
Kolb, Edward Anders
Murphy, Erin S.
Museal, Jodi A.
Pierson, Christopher R.
Reed, Damon
Schore, Reuven
Unguru, Yoram
Venkatramani, Rajkumar
Wistinghausen, Birte
Dhall, Girish
PEDIATRIC BLOOD & CANCER, 2019, 66 (10)
[36] Social attainment in survivors of pediatric central nervous system tumors: a systematic review and meta-analysis from the Children's Oncology Group
Schulte, Fiona
Kunin-Batson, Alicia S.
Olson-Bullis, Barbara A.
Banerjee, Pia
Hocking, Matthew C.
Janzen, Laura
Kahalley, Lisa S.
Wroot, Hayley
Forbes, Caitlin
Krull, Kevin R.
JOURNAL OF CANCER SURVIVORSHIP, 2019, 13 (06) : 921 - 931
[37] Presenting symptoms and time to diagnosis for Pediatric Central Nervous System Tumors in Qatar: a report from Pediatric Neuro-Oncology Service in Qatar
Maaz, Ata U. R.
Yousif, Tayseer
Saleh, Ayman
Pople, Ian
Al-Kharazi, Khalid
Al-Rayahi, Jehan
Elkum, Naser
Malik, Muzaffar
CHILDS NERVOUS SYSTEM, 2021, 37 (02) : 465 - 474
[38] Supportive care in pediatric oncology: Considering children and AYA's special needs
Poiree, Marilyne
Duplan, Mylene
Letort-Bertrand, Maina
Thouvenin, Sandrine
Deparis, Mariana
Galland, Francoise
Aladenise, Clementine
Lervat, Cyril
BULLETIN DU CANCER, 2022, 109 (05) : 557 - 567
[39] Neuro-oncology family caregivers' view on keeping track of care issues using eHealth systems: it's a question of time
Boele, Florien W.
van Uden-Kraan, Cornelia F.
Hilverda, Karen
Weimer, Jason
Donovan, Heidi S.
Drappatz, Jan
Lieberman, Frank S.
Verdonck-de Leeuw, Irma
Sherwood, Paula R.
JOURNAL OF NEURO-ONCOLOGY, 2017, 134 (01) : 157 - 167
[40] Serum protein expression profiling in pediatric Hodgkin lymphoma: A report from the Children's Oncology Group
Qi, Lining
Cazares, Lisa
Johnson, Cris
de Alarcon, Pedro
Kupfer, Gary M.
Semmes, O. John
PEDIATRIC BLOOD & CANCER, 2008, 51 (02) : 216 - 221

← 1 2 3 4 5 →